BNIP3 and breast carcinoma: Researchers reported that upregulated FTO enhanced the development and metastasis of breast cancer cell through downregulation of BCL2 interacting protein 3 (BNIP3) expression in both vitro and vivo experiment (Niu et al., 2019).